Cannabis

Recently, the psychedelic market garnered the attention of investors as the industry was catalyzed by IPOs from MindMed Medicine and Champignon Brands with both companies quickly reaching market caps of over $100M due to significant demand in this new space. [more]

Canopy Growth, the largest cannabis company in the world based on market cap, reported full year earnings for F2020, with a 73% increase in revenue year-over-year, however, its bottom line reached over C$1 billion in losses due to restructuring initiatives, costing upwards of C$700 million. [more]

As the coronavirus negatively affects the business world and companies cut or pull guidance, here are three companies, backed by recently released financial results, which have reaffirmed growth guidance for 2020 – Sangoma, Trulieve and Xebec. [more]

Revenue growth expected from cultivation and retail operations in California, Illinois and Pennsylvania, and from recent Origin House acquisition. [more]

Other major events and reports related to the cannabis industry include: Cannabis Treatments for COVID-19; Canopy Growth loses two executives; Green Thumb Industries triples revenue; Tilray hopes to be profitable by year-end; United Cannabis files for bankruptcy. [more]

State-of-the-art cultivation and manufacturing facility expands capacity by 66,000 sq. ft to a total of 88,000 sq. ft of indoor and greenhouse space. [more]

Lorimer Wilson from MunKNEE.com reviews 35 cannabis companies and 29 had stock price increases in April with only 6 companies going down in price. [more]

S&P 500 and S&P/TSX indices screens highlight companies with strong balance sheets and cash flows, which reduce liquidity risks and allow companies the ability to acquire distressed assets. Cash Kings – Alphabet, Microsoft & Facebook in the U.S. and Onex & Kirkland Lake in Canada [more]